ICPMS
Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Language Čeština

    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma | LabRulez ICPMS

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Sanofi-aventis - A high throughput assay for oxaliplatin in clinical samples

    Others
    | 2007 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Agilent ICP-MS Journal (August 2011 – Issue 47)

    Others
    | 2011 | Agilent Technologies
    ICP/MS, Speciation analysis
    Instrumentation
    ICP/MS, Speciation analysis
    Manufacturer
    Agilent Technologies
    Industries
    Environmental, Pharma & Biopharma

    Simplified QC for Pharmaceutical Elemental Impurity Analysis

    Others
    | 2017 | Agilent Technologies
    ICP/OES
    Instrumentation
    ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

    Manuals
    | 2018 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Enterprise Content Manager (ECM)

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Residual Catalysts in Pharmaceuticals Using ICP Atomic Emission Spectrometry

    Applications
    | 2010 | Shimadzu
    MP/ICP-AES
    Instrumentation
    MP/ICP-AES
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Handbook of ICP-QQQ Applications using the Agilent 8800 and 8900

    Guides
    | 2022 | Agilent Technologies
    GC, HPLC, ICP/MS, Speciation analysis, ICP/MS/MS
    Instrumentation
    GC, HPLC, ICP/MS, Speciation analysis, ICP/MS/MS
    Manufacturer
    Agilent Technologies, Elemental Scientific
    Industries
    Environmental, Food & Agriculture, Energy & Chemicals , Pharma & Biopharma, Materials Testing, Semiconductor Analysis , Clinical Research

    WCPS: Single-Cell and Bulk ICP-MS Investigation of Accumulation Patterns of Pt-based Drugs in Cisplatin–Sensitive and –Resistant Cell Models

    Posters
    | 2023 | Agilent Technologies
    ICP/MS, ICP/MS/MS
    Instrumentation
    ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma, Clinical Research
     

    Related content

    ‌

    Advances in Chromatography and Electrophoresis & Chiranal 2024 (Programme)

    Mo, 13.5.2024
    Advances in Chromatography and Electrophoresis & Chiranal
    ‌

    Mother’s protein intake during pregnancy can affect newborn’s facial development

    Su, 12.5.2024
    CEITEC
    ‌

    Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call

    Th, 9.5.2024
    Ústav organické chemie a biochemie AV ČR
    ‌
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike